Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AT 02

Next Previous
Drug Profile

AT 02

Alternative Names: AT-02

Latest Information Update: 14 Nov 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Attralus; University of Tennessee
  • Developer Attralus
  • Class Immunoglobulin fusion proteins; Peptide fragments; Recombinant fusion proteins
  • Mechanism of Action Phagocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Amyloidosis
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Amyloidosis

Most Recent Events

  • 12 Nov 2024 AT 02 receives Orphan Drug status for Amyloidosis in USA
  • 29 Jul 2024 European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) recommends orphan drug designation for AT 02 in European Union for Amyloid light chain amyloidosis and Transthyretin related hereditary amyloidosis
  • 21 Sep 2023 Phase-II clinical trials in Amyloidosis in Australia, USA (IV) (NCT05951049)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top